empirica Representative Joins the Editorial Board of Healthcare IT Management

empirica Communication and Technology ResearchHealthcare IT Management, a publication of the European Association of Healthcare IT Managers, covering the European healthcare IT sector, has invited Dr. Karl Stroetmann to join the editorial board for a three-year period. The magazine reaches an impressive and advanced audience from hospital IT managers to policy-makers.

Dr. Stroetmann will share his long standing expertise in the European and global eHealth markets covering policy developments and strategic issues (eHealth Era Project), socio-economic evaluation and technology assessment of complex eHealth applications (Study on Economic Impact of e-Health, EHR IMPACT study) as well as long-term advanced research in fields like the "Virtual Physiological Human (VPH)".

empirica Communication and Technology Research welcomes this opportunity to contribute to a renowned journal which promotes common management standards and good practices at a pan-European level.

Related news articles:

About the European Association of Healthcare IT Managers
The European Association of Healthcare IT Managers (HITM) is a non-profit organisation outlined as the pan-European umbrella association of all relevant national healthcare IT associations in Europe.

Believing in the fundamental importance of unifying healthcare IT professionals at European and global levels, HITM is committed to increasing the professional authority and responsibility of healthcare IT managers and representing their interests to international institutions and associations.

For further information, please visit http://www.hitm.eu.

About empirica Communication and Technology Research
empirica Communication and Technology Research is a private research institute originally founded in 1976 and based in Bonn, Germany. It specialises in communication and information technology related research and consultancy to clients in both the private and public sector. Its expertise covers long-term R&D and roadmapping, policy and strategy development as well as EU-wide representative market research. The company has gained a strong profile in the development, pilot-testing and market validation of IST-based healthcare services. It observes and interprets market trends and evaluates the socio-economic impact of eHealth applications. In addition, it regularly conducts foresight exercises, representative surveys and compiles data bases of good practice case studies with the support of a dense network of contacts in government, industry and academia.

For further information, please visit www.empirica.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...